<SEC-DOCUMENT>0001640334-19-000543.txt : 20190404
<SEC-HEADER>0001640334-19-000543.hdr.sgml : 20190404
<ACCEPTANCE-DATETIME>20190404061613
ACCESSION NUMBER:		0001640334-19-000543
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190402
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190404
DATE AS OF CHANGE:		20190404

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inmune Bio, Inc.
		CENTRAL INDEX KEY:			0001711754
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475205835
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38793
		FILM NUMBER:		19731162

	BUSINESS ADDRESS:	
		STREET 1:		1224 PROSPECT STREET
		STREET 2:		SUITE 150
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		8589643720

	MAIL ADDRESS:	
		STREET 1:		1224 PROSPECT STREET
		STREET 2:		SUITE 150
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>inmb_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html><head><title>inmb_8k.htm</title><!--Document Created by EDGARMaster--></head><BODY spellcheck="true" style="text-align:justify;font:10pt TIMES NEW ROMAN;margin:0px 7%"><p style="MARGIN: 0px" align="center"> <table style="FONT-SIZE: 1px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td> <div style="HEIGHT: 4px; WIDTH: 100%; BACKGROUND: #000000; MARGIN: 0px 0px 2px" name="hrule"></div> <div style="HEIGHT: 2px; WIDTH: 100%; BACKGROUND: #000000" name="hrule"></div></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><font size="3">UNITED STATES</font></b></p> <p style="MARGIN: 0px" align="center"><b><font size="3">SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style="MARGIN: 0px" align="center"><b><font size="3">Washington, D.C. 20549</font></b></p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><font size="5">FORM 8-K</font></b></p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>CURRENT REPORT</b></p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center">Date of Report (Date of earliest event reported): <b><b>April 3 </b>(<b>April 2, 2019</b>)</b> </p> <p style="MARGIN: 0px">&nbsp;</p> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="40%" align="center" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px" align="center"><b><font size="5">INMUNE BIO INC.</font></b></p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="center">(Exact name of registrant as specified in charter)</p></td></tr></table> <p style="MARGIN: 0px">&nbsp;</p> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="85%" align="center" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="30%"> <p style="MARGIN: 0px" align="center"><b>Nevada</b></p></td> <td valign="top" width="5%"> <p style="MARGIN: 0px" align="center">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="30%"> <p style="MARGIN: 0px" align="center"><b>001-38793</b></p></td> <td valign="top" width="5%"> <p style="MARGIN: 0px" align="center">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="30%"> <p style="MARGIN: 0px" align="center"><b>47-5205835</b></p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="center">(State or other jurisdiction</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">(Commission</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">(IRS Employer</p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="center">of incorporation)</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">File Number)</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="center">Identification No.)</p></td></tr></table> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><u>1224 Prospect Street, Suite 150, La Jolla, CA 92037</u></b></p> <p style="MARGIN: 0px" align="center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><u>(858) 964 3720</u></b></p> <p style="MARGIN: 0px" align="center">(Registrant&#8217;s Telephone Number, Including Area Code)</p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><u>Not Applicable</u></b></p> <p style="MARGIN: 0px" align="center">(Former Name or Former Address, If Changed Since Last Report)</p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u>&nbsp;General Instruction A.2. below):</p> <p style="MARGIN: 0px">&nbsp;</p> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td width="4%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top" width="4%"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font></font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font></font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font></font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font></font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Emerging growth company&nbsp;<font face="Wingdings">x</font></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font></font></p> <p style="MARGIN: 0px" align="justify">&nbsp; &nbsp;</p> <p style="MARGIN: 0px" align="justify"> <table style="FONT-SIZE: 1px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td> <div style="HEIGHT: 2px; WIDTH: 100%; BACKGROUND: #000000; MARGIN: 0px 0px 2px" name="hrule"></div> <div style="HEIGHT: 4px; WIDTH: 100%; BACKGROUND: #000000" name="hrule"></div></td></tr></table></p> <p style="MARGIN: 0px"> <table class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td>&nbsp;</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p><b> <p style="MARGIN: 0px" align="justify"><b>Item 8.01 Other Events </b></p></b> <p style="MARGIN: 0px" align="justify"><b>&nbsp;</b></p> <p style="MARGIN: 0px" align="justify"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On April 2, 2019, INmune Bio, Inc. (the &#8220;Company&#8221;) issued a press release (the &#8220;Release&#8221;) announcing that its Chief Executive Officer, Raymond J. Tesi (&#8220;CEO&#8221;), Chief Financial Officer, David Moss (&#8220;CFO&#8221;) and Chief Scientific Officer, Professor Mark Lowdell (&#8220;CSO&#8221;), together with other members of the Company&#8217;s management team will ring the NASDAQ closing bell on Tuesday, April 9, 2019. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A copy of the Release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. Exhibits 99.1 shall not be deemed &#8220;filed&#8221; for purposed of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.&nbsp; </p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp; <p style="MARGIN: 0px" align="justify">Item 9.01 Financial statements and Exhibits</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p></b> <p style="MARGIN: 0px" align="justify">(d) Exhibits.</p><b> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="10%"> <p style="MARGIN: 0px" align="justify"><b>Exhibit Number</b></p></td> <td valign="top" width="2%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px" align="justify"><b>Description</b></p></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify"><a href="inmb_99.htm">99.1</a></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><a href="inmb_99.htm">NASDAQ Closing Bell Release dated April 2, 2019</a></p></td></tr></table></p> <p style="MARGIN: 0px" align="center">&nbsp;</p></b> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"> <table id="pagebreak433eddac-2d8b-4331-9726-8e731025a7cd" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">2</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>SIGNATURE</b></p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 45px" align="justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="MARGIN: 0px">&nbsp;</p> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px" align="justify"><b>INMUNE BIO INC.</b></p></td> <td></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top" colspan="2"></td> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td></tr> <tr height="15"> <td valign="top" width="50%"> <p style="MARGIN: 0px" align="justify">Date: April 3, 2019</p></td> <td valign="top" width="3%"> <p style="MARGIN: 0px" align="justify">By:</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="35%"> <p style="MARGIN: 0px" align="justify"><i>/s/ David Moss</i></p></td> <td width="12%"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">David Moss</p></td> <td></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">Chief Financial Officer</p></td> <td></td></tr></table> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"> <table class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">3</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p></BODY><!--Document Created by EDGARMaster--></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>inmb_99.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head><title>inmb_99.htm</title><!--Document Created by EDGARMaster--></head><BODY spellcheck="true" style="text-align:justify;font:10pt TIMES NEW ROMAN;margin:0px 7%"><p style="MARGIN: 0px" align="right"><b>EXHIBIT 99.1</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">&nbsp; </p> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b><font size="3"><img src="inmb_99img1.jpg"> </font></b><b><font size="3"></font></b></p> <p style="MARGIN: 0px 0px 0px 0in" align="center">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b><font size="3">INmune Bio to Ring the NASDAQ Closing Bell on Tuesday, April 9, 2019</font></b></p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in"><b>La Jolla, CA &#8211; April 2, 2019</b> &#8211; <u>INmune Bio, Inc.</u> (NASDAQ: <u>INMB</u>) (the &#8220;Company&#8221;), an immunology company focused on developing treatments that harness the patient&#8217;s innate immune system to fight disease, today announced its Chief Executive Officer, Raymond J. Tesi, Chief Financial Officer, David Moss, and Chief Scientific Officer, Professor Mark Lowdell, will be joined by other members of the management team to ring the NASDAQ closing bell on Tuesday, April 9, 2019, to celebrate the Company&#8217;s successful initial public offering (&#8220;IPO&#8221;) in February 2019.</p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in">&#8220;On behalf of the INmune Bio management team and our board of directors, we are honored to celebrate our recent IPO by ringing the NASDAQ closing bell,&#8221; said Raymond J. Tesi, Chief Executive Officer of INmune Bio. &#8220;Our successful IPO has provided us with financing to pursue the continued advancement of our immunotherapy programs that harness the power of the innate immune system in multiple, critical clinical trials. Our team will continue to focus on developing innovative treatment alternatives to fight cancer and neurodegenerative diseases.&#8221;</p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in">The INmune Bio closing bell ceremony will be broadcast live starting at 3:45PM (Eastern Time) from the NASDAQ MarketSite Tower in New York by visiting http://livestream.com/nasdaq/live.</p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in"><b>About INmune Bio, Inc.</b></p> <p style="MARGIN: 0px 0px 0px 0in">INmune Bio, Inc. is a publicly traded (NASDAQ: INMB) clinical-stage biotechnology company developing therapies targeting the innate immune system to fight disease. INmune Bio is developing three product platforms: two products that reengineer the patient&#8217;s innate immune system&#8217;s response to cancer and one product to treat neuroinflammation that is currently focused on Alzheimer&#8217;s disease. INKmune is a natural killer (NK) cell therapeutic that primes the patient&#8217;s NK cells to attack minimal residual disease, the remaining cancer cells that are difficult to detect, which often cause relapse. INB03 inhibits myeloid-derived suppressor cells (MDSC), which often cause resistance to immunotherapy, such as anti-PD-1 checkpoint inhibitors. XPro1595 targets neuroinflammation, which causes microglial activation and neuronal cell death. INmune Bio&#8217;s product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and chronic inflammation. To learn more, please visit <u>www.inmunebio.com</u>. </p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in"><b>Forward-Looking Statements </b></p> <p style="MARGIN: 0px 0px 0px 0in">This press release contains &#8220;forward-looking statements&#8221;. Forward-looking statements reflect our current view about future events. When used in this prospectus, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;future,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this prospectus relating to our business strategy, our future operating results and liquidity and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward&#8211;looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.</p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in">Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.</p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in"><b>INmune Bio Contact: </b></p> <p style="MARGIN: 0px 0px 0px 0in">David Moss, CFO</p> <p style="MARGIN: 0px 0px 0px 0in">(858) 964-3720</p> <p style="MARGIN: 0px 0px 0px 0in">DMoss@INmuneBio.com</p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in"><b>Media Contact: </b></p> <p style="MARGIN: 0px 0px 0px 0in">Antenna Group</p> <p style="MARGIN: 0px 0px 0px 0in">Sharon Golubchik</p> <p style="MARGIN: 0px 0px 0px 0in">(201) 465-8008</p> <p style="MARGIN: 0px 0px 0px 0in"><u>INmuneBio@AntennaGroup.com</u> </p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in"><b>Investor Contact: </b></p> <p style="MARGIN: 0px 0px 0px 0in">KCSA Strategic Communications</p> <p style="MARGIN: 0px 0px 0px 0in">Valter Pinto / Scott Eckstein </p> <p style="MARGIN: 0px 0px 0px 0in">PH: (212) 896-1254 / (212) 896-1210</p> <p style="MARGIN: 0px 0px 0px 0in"><u>INmune@KCSA.com</u> </p> <p style="MARGIN: 0px">&nbsp;</p></BODY><!--Document Created by EDGARMaster--></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>inmb_99img1.jpg
<TEXT>
begin 644 inmb_99img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "4 .8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_8 8' Z#
MM[4N!Z#\J!T'T'\J6@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#
M\J6B@!,#T'Y48'H/RI:BE=D (QR<<@GMQT]3]*%KIW DP/0?E5&6XBBCWL0$
MR>1'NQCDDC' [;FP,GK2FY*J7<H@4$OSC '.<'//)XR2>.E?D/\ M9_M\WFF
MZU)\'?V=XU\1>.IM0BT+4O%FGVHUF/3]8EE2U_L7P?IOER1^(_$23R"!IPLU
MC87&+9TGNG_<=^797BLUKJCA8O>]2K]BG"Z<I-[+3\?F?(\7<8Y1P?ESQ^8U
MDYRCRX;!4W_M6*J-QY:=&&_-WV5GJS](OB#\;?AA\*;#^TOB#XT\->%[5E62
M)=7OK>VO+H'D)::<"U_>R=O+M;:>0N<*I.!7PWXI_P""H_P"TF:XB\.:'XX\
M:/#,8EETOPY#IME*0>6@GURZT^ZD!4$Y^RXZ [2>/YF?VE_VGK3X?^/+CP0U
MUX@_:5_:IUW4WTBZ\$>&;_4?%<7A;Q1<.4.@^)_$&D1ZK<Z[XKBED87'PW^'
MEM>RZ)<1?9M;U[198);8];\.?^"1'_!4C]J^*#Q'\8_'>B?LR>"]66.XLO#'
MB.]OY/$,=K*6_='X>^ [M)-,EVH"R^*?%Z:BKGS[BV23<K?L.7\!<)99A88S
MB?/HX6$X*2I;5JK48M^RIKFJ./G;T6EC^=,3XG^*'%N/6&X1R*."PE[NOB:4
MJTX*3BDIR:5-2LM5+2_0_?*'_@K[\(H[LV^J_#[Q/I<0S\S:UX*>Y 4D-OLY
M]9M61T/!0S'!P,@GGZ%^&O\ P4?_ &9?B UO;OXLN?"=W.R[8O%&E?9;023$
M>6IUC33J>A*B9PUQ)J$4.05,P96%?B#I'_!L/X)FM@_BK]L7Q_J&J,B>=<Z/
M\-?#5M:_:"IW /J?B/6+RXCW9P9IUG8$[W#'(\S\?_\ !MG\6/!L<VK?L\?M
ME6EWJUO#+(-*\=>%=9\&RRSQH3#$GB#P1XAU9+02OMC^T76@7$$:A=ZL@8UC
M++O"#%REAZ.?X_"56^6GB)T*OL>?W4N9R@TU=]'YW21]-A,1XXY=&&,QM/!Y
MC223>&5*E3G)+E;4?9M/FLK)?\ _KCTWQ+I6MV-KJNCZE8ZMIEY$MQ:WNFRV
M5[975NY&V>VO(#+;3)C:X>*1U/09(&/&/V:OBW=_%WP+=:MJ1MIM6\.^.O'?
M@+5YH(+6&*ZNO"/BR_TJVOH([=%CB%YI$>FW,D('RL">I-?RY_L>6O\ P54_
M8I_: M_AY^T#H.KZ9\!-.\+^*/''CGX@7]Q8>)_AI>Z#X;TIY+/2_#OC'3)'
MTRZ\8>*O$$_A_0=#TS4+32_%1;5+FX6U:*WN4'[F?\$M[V2X^#>OW&JWT UG
MQ%\4O%?B:.PGGSJ-Q;/!HUEJFJ);3&.XDM3JD[6LUY'$]M'=H8)9A<L$/Q&?
M<,X;*88FKALRP^:8=2HO#XC"OGIRA-76VB<5;F5WJ_D_K.'/$3,\YXBRS)<=
MEU3*Z\L/BJF-H5WRSYJ?L_9M*6O+*\K-_+S_ %7P/0?E1@>@_*H]_H5/TS4@
M.1FOBE)-M)W_ $T7XZG[.&!Z#\J,#T'Y4M%4 F!Z#\J,#T'Y4M% "8'H/RHP
M/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J*6B@!!T'T'\J6D'0?0?RI: "BBB@ H
MHHH ****  C/!JK=310HKS':-X"G:6^8AL 84G<WW0.Y( Y-6JP/$-Y%8:?+
M>7#Q1VUK')<7+S,%2."&-Y9I<G@>4D9?=P5 )'/2H1E.<(05Y2E&*]6TOPW,
M,5B(X7#UL3-VC0IRJR;V2@KMOT6I^8W_  44_:COOA]H&F_!WX<:A.GC[X@P
MQR:C>:<7_M+0O"MS,UBJV B_>C7/$EZ1INDH0LBVCWEW"5<6CM^!W[0^J?$K
MX>>*_ W[!?[*ME-K'[=/[0&FVI^*OBS1YW\SX ?#?Q'8"Y'@[3-?B0_\(OXC
MU+19AK?Q+^(+PI>:!X9>.RTEFNO$&FO']Z> O'>F>-/BY^TG^VW\4[=;CX=_
ML_\ ASQ-\3;=+MF$32Z'INHQ?#[14WXB5K71]+DNH(N5&KM87#!<(S=9_P $
M,?V:]6U?P/\ $;_@H7\;%FU/X^_ME>(_$'BBQU+58FDO/#_PIGUR>;2[#3OM
M(+VEKXEU" 7Z1PL@'A;2?!^GJQ@L&1OU*GB,#PSEU-NG"K5PD85)]8U\QK13
MI4Y?S4Z$7S3I_:O"^]C^7,)@<5XB<65\XQ3G+!U:E3#953G:5&A@,/*,:^*I
MQDK*K6G=0GNDI6W/KG_@G=_P2T^!O[!O@FROK#3;'Q]^T!JEA#_PG'QGU2RA
M;4!=7*FYNM$\#Q7)=_"?@J)I9+:*WLRNI^( !?>)+O4+F?;%]_?#3XC:9\1-
M0\<P:2K76G> ?&=WX'N=4DQ*EWKNCZ=:3:ZUJI )MK*]O4L(W6/#R)/(O[O;
M7>Z[NTO1]5O+5B9+6SO+N)0%XD6"295*  ,ID1'&1EG#< '%?EQ_P2N\?1^(
M? 'Q0\+7]P)/$%I\2-4\6W_G2^9/>Q^-88KZ74"C-N:,ZK9ZC;Y7*Q^3$K$$
MX/\ /7%?'.(GQ7E6 Q^(E/$YG+$SA.H[4_W4(2A1A%OEBVY<JC%62LE;K_0>
M$I9?P_/+LJPE"G2IU8/507--TXP]Z4K7DV]7U>^FY]%_M&?MQ_!_]GWQ5I_@
M_7X=?U[Q+=:?!J-[I?AG3K>\?1](OGD2WO=3EOKRSMXS?+#,UM90%[ZX@C\P
M"")XV?Z1\ _$CP?\3? .@^-_">IIJ7AKQ'I4>IZ;J'V>6%?+#&.6.[CF4O;7
M-A<Q20WUM.Q:VFAD65MHWU^?G[7W[ 5W\;_B"/BGX6\?V/A/4K_1[#3O$]GK
MVEW.HZ=<'1TDM['5[*6RN;:2UNELVCM[VWF(MKB.UCG22%Q+GX4^,O[2=C\-
M/AAI?[*7P"\07E[X9\+VE]HOC?XH1.8+KQ3>337%_J^E>'KJ E8K"XO;FXCU
M'48))(;NV9=%TJY14DGDY?#O+_$CB7C7,,#F&7PH<-4IN>'QO(G&,8V;;:6E
MXK5W2/B>,?$./ SS#$YQ*C.G*A*658>G44L17J2Y8QBJ5V[\VE[=%;SZS]O+
M]J-_C/XHLO@M\,9IM7\*>'_$%C'>W6E@R?\ "<^-OM2V6DZ9I9C1C)INCZHX
MAM_*+1ZAJQDN$>1+"$O\:?\ !1OX1?MA_L#:K^RA^VU\!M7CU3P1^S]\,!\.
MOBAH6GK>"QTW5_&_B^3Q)XZF\>6"3O!K'PP^(FJWEOHLFHQQI/X)UVQT_5R0
MUQ:36OZ(_P#!.K]DR]U>[L/C_P".M.DLM(T\L?A=I4T+$W=W+']FG\<3VMPH
M(M;6)I+?P\)D\QW$FL@#;9.W[(^,_A]X7\>^#?$O@OQMIEKXC\(>*-$U#P]X
M@\.ZG;PW6FZOHNI6<UE?V%S!(NV2*[M)?+<DAP_E2HR7$:2#^A\QSW+LEQ6!
MRG!T*>-P>$G*.8\T8SCB958PC4OM9P7,X-:*72R/@>!.%L]XH6;<=YU*K@,R
MS.A3EDL&Y0EA,/"7/!<O15-.=-:QUUW/"?V,OVI/ '[7?P)\$?'CX>7,PT'Q
MCII74M&NYUN=8\'>,--G:U\4>"M?$;L;?5/#NI"2W"M&C7EHT.IKNMKRU=_K
MN*198@\9.#GDJ0>&(/RD ]01^M?R:_\ !+6Z\1?\$[_^"G/[1G_!-CQ1J^H7
M/PX^)D<_CKX*3:D-T5U=Z-HI\1>&;^W;SFACO?$GPX;4O#^MF-6GO]:^'4#S
M2&8I'7]8EFV^V0ALG+9;!!R22<@]QG'/L:^1XDRNGE>:26%E&> QM&GCL#./
M6A7A&48NVBG3?-":WO&[6I^W\'YK7S++%#&1<<=@9SPF+4KW]M1:3DD_LS5I
M1[7ZERBBBO!/K HHHH **** "BBB@ HHHH 0=!]!_*EI!T'T'\J6@ HHHH *
M*** "BBB@! ,=/ZU\Y?M::])X8_9U^,.M0L4N+;X?^)8H)1G,$]_IL^G13C'
M/[F2Z67CGY".]?1U?-G[6^A2^*/V=?B_HEN6\^[\ ^(I855=[RO96$U]Y,<8
M(+/(+4QC!R"<@$X![<N2>.PBD[)UZ2;Z?&M_+>_YGSW%CFN&L[<%>7]G8JW?
M^'+;N_+KL?SH?M%:1J?AO_@C)\3=)T=9;?Q#^T9\8OAY\+DN(&$3S6OBSXG>
M$?!T-H[X)2">QTN^LS$/W>^^ER/+D<M_31\(OAOI/PI^'?@'X=^'[-;31/!'
M@GPOX.TNV18UC@L/#FBVFDP#"A0SE+197(7YIY;B;/F2NS?@5\6;"S\6?\$C
M?"GB*.57C^#W[0_P2^).N-'R+?2?!/[37@[4O$5W.2/W<.G^&=3N]2NF*,$A
M@8D%"6'](,4ZR)#(FUHF5"LBG*LC!71E*@@JRD,"O4$'FO9XEQ%90G1<=(XW
M$<SZWBL/%-V:Z6L]=%IL?&>&674*>4X&K!+FCE^&E3LDK>U3E46NJ]_64;[M
MW12O[4SI-&\8>&:)D="J[67:ZE&#?>R'XR-N0<X!K^>G]G?0_B1^S]^WIXG\
M!>&M'FO]%36=>M/&,5W+'8V$/PDU&Y?7M(\6SW+?Z+9G1S=VTVE0MM-[,-0T
M>.<F7=#_ $1SR[?F.0H'8_I@C&/YG(XZU^&O_!0G]HG3=,\3>(/@_P##DV%I
MXCU>QT^V^+GB_2;:"+6I-)@ADN=%\!/JEL/MTTK6EZ]YJWF2(;;3M0%G;R6R
M75T@_+L3X5R\1N*N':N'Q,\%6R;'0Q;K*/NRP_)'VD)OIS6ZZ][C\4.(<OX4
MR>GGU:JOK67593PN'O:KB*LU%*DE:\DVDDMEKZ'%?MK_ +<E]\1I=:^$WPDU
M>6T\$PR3Z;XE\7:?-(ESXTE0R)>Z5H=S;D_9?"R$F.]U&!Q/K(2>TM&2U25Y
M>$_8F_8PO_C9J=A\0OB#97%G\)-*G632].F1EN/'EQ;2+F*%?D>+PK;29^W7
M6W_B9,3:6V+<33MY_P#LM_L^^$_&ES9_$SXWZ[8^$?@CHGB&P\/PS:W>KI47
MCOQ3<W,=M8>%M/N N%T.*Y58=7EMQ&ETNZWMWBB@O[M/Z7=!T;2--TO3K32;
M>TL],M+6WM]/L[.&*"RMK."-5MX+6"#9##%!$$C@CB4(L:*&63"D?T%G_$F3
M\*8;_5+AVOAY8^G04<PQ-.I&=93<8J=U%\ZOJM;62\C\'\/>!LV\5,]CQYQQ
M.I]4I5O:9;E$FU&%'FYJ;E3V:M9ZK5[VL7-'TNTL;*WL;.WCM;2R@MX+2WA@
MCAM((8H_+CBLXHPJQP11*D<:*J*JJ%554 5KS1CR)4VY'EL!R 3P>_;FEB(7
M<H&U5P!UZ8[<'N?7I2SY,,N 2=C8 ZG SC\>E?E+E*I)R<FW4:E*763:6NO=
MZZ^GI_8U.A2P]"&&I4U"C2@J<*<4K1A&*222TV2TV/Y@_P#@KKX=G^%7_!2O
M_@E)^TMHB_9M0U7XH6/P@UVX7$4E]:1>,]%:UMYFC*.T"Z/XZ\56I\TD,K6L
M1&R/ _IRT[/V8?,[#+ %\EN"1[[AC&#^77 _GL_X+%:8?'W[6W_!(GX3V"B;
M7=7_ &KI_%LD*@N\6B>%V\+:EJ-[.BY:.VCBM)Y'<;E5XPK<9-?T)Z<P:V&/
MNJ\BKGL%D8#/?(QWYX[5]3G<XU<EX=;M[>&%Q49=_9+%.-"[O>SM-J/17TLC
MXWARE4IY[Q(XJV'GB*32Z*K[.+FO/>-WOM>YH4445\J?;A1110 4444 %%%%
M !1110 @Z#Z#^5+2#H/H/Y4M !1110 4444 %%%% "'H?H?Y5SWB&PM]3TV>
MQNX?/M;VWN;6ZC*@[[:>"9+A#P3M:-R,=^#CK7154NT+K'AMI6:-\^H3.5^C
M E3_ +)(&"<U4)NG*,T[.$DTT[?"T[7]5;_@F&*HQQ.'JT)J\*L'3DGLU+1I
M^I^(_P"S9\.M)FLOVP/V"/B@SKHFM6WBA=,^UHV;SP?XSTJ7PY)K&G^9M9I+
M-)/#FLPRJA5+F2213_HS$?J!^S?K?B34OA)X&T[QM<3S>/\ POH=OX'^(:SL
M7>3QQX)AAT#Q#J8<XS;:[<V8U_3^JR:=JMG*"TAE8_+/[7WPJ\5^&/&'@K]J
MOX36%UJ7CCX7;8_&GABP57F\>?#@>8-<L"FQY;J_TG3[F\EMTC\R=K:<F%)K
MJWME7Z^^$7CKP5\1_"^B^/\ P'=VU_H?BO3DU'[3;D+,UPD26TEOJ<?F-Y.J
MZ8T0TS4+=D%U:2P1VLJQQ1X/MYS..-I4<?3;E&M3A[>"7O0KQ45)V7\UE*ZW
M:UVU_.^#HSR3%XK(<7>G.AB:M3!5)Z*MAJDU.$8[+]VKQLEM\RK\>OB1!\*?
MAEXY^(-R3+!X5\+WVI);?.R7%^H:+3X'"[3FXU"6SA8@Y\J1^NP _P TGP(^
M&/BG]ISXZV&@W%W>27GB+4[KQA\1M>4LTUKHK7<-SK=QYDFXM=WMS<-I>F)&
MP>'[3:,<)$%7]Q/^"C\]TG[+OC>*$3>1<:EX0BO!$0IEM9?$]AO@9LC$;R10
MB0ME45MQ#8-?,'_!)GPG8O;_ !8\<-'&=2DU?0_#<<A0(UO86^F'6[F*,*<
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MF&$Q/!>887&8#G643E2H5,/%^Y2A&,(6Y5HD[73TUZ(_KLB>-UP&5N%)P>Q
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MM'VGP!F_9W'PT2X\#^*_&1\4CXC1>)VC_P"$7?3HO[.&DIX9TPR?:WU&-?M
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MEM[=DMA*LA.PG'WW_P %T_V*?VE/VU?#?[->G_LW^ [+QQ-X!\3?$+5_%O\
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M)+#Q'X>U&TF\O'EQQ+_?+#Z\_P""=O\ P2)_;\_9]_;7_9N^,?Q4^#>B:)X
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=M+1LU<8RJT)2BI25-M2:3DM%LWJ=31114G2?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
